| Synonyms: | |
| Status: | Phase 1 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 45II35329V |
| InChI Key | RGYQPQARIQKJKH-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C21H19ClN4O2 |
| Molecular Weight | 394.86 |
| AlogP | 3.4 |
| Hydrogen Bond Acceptor | 5.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 3.0 |
| Polar Surface Area | 63.03 |
| Molecular species | ACID |
| Aromatic Rings | 4.0 |
| Heavy Atoms | 28.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | NADPH oxidase 1 inhibitor |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | 110 | - | |
|
Enzyme
Transferase
|
- | - | - | - | 2.444-13.88 | |
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -39.19--4.44 | |
|
Transporter
Transmembrane 1-electron transfer carriers
|
- | - | - | 140 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Idiopathic Pulmonary Fibrosis | 2 | D054990 | ClinicalTrials |
| Liver Cirrhosis, Biliary | 2 | D008105 | ClinicalTrials |
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Nephritis, Hereditary | 1 | D009394 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4303187 |
| EPA CompTox | DTXSID30153432 |
| FDA SRS | 45II35329V |
| Guide to Pharmacology | 9932 |
| PubChem | 58496428 |
| SureChEMBL | SCHEMBL1302603 |
| ZINC | ZINC000095670835 |